クローン病におけるレバミゾール

Downstaging of colorectal cancer by the National Bowel Cancer Screening programme in England: first round data from the first centre.

Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland·2009

Earlier diagnosis and treatment of symptomatic bowel cancer: can it be achieved and how much will it improve survival?

Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland·2009

Bradykinin regulates human colonic ion transport in vitro.

British journal of pharmacology·2008

Infliximab therapy in Crohn's disease: a pragmatic approach?

Alimentary pharmacology & therapeutics·2006

Functional categories of TP53 mutation in colorectal cancer: results of an International Collaborative Study.

Annals of oncology : official journal of the European Society for Medical Oncology·2006

Pathological response following long-course neoadjuvant chemoradiotherapy for locally advanced rectal cancer.

Histopathology·2005

1-month versus 12-month dual antithrombotic therapy after percutaneous coronary intervention in patients with atrial fibrillation (OPTIMA-AF): a multicentre, open-label, hybrid non-inferiority and superiority, randomised, controlled trial.

Lancet (London, England)·2026

Multidomain lifestyle intervention for the prevention of cognitive decline in at-risk older adults in Latin America (LatAm-FINGERS): a single-blind, multicentre, randomised controlled trial.

Lancet (London, England)·2026

Advancing the relevance of clinical trials for older patients.

Lancet (London, England)·2026

Temocillin versus carbapenems for bacteraemia due to third-generation cephalosporin-resistant Enterobacterales in Spain (ASTARTÉ): a multicentre, phase 3, open-label, non-inferiority, randomised clinical trial.

Lancet (London, England)·2026

Fixed-duration pirtobrutinib plus venetoclax-rituximab versus venetoclax-rituximab for patients with previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (BRUIN CLL-322): an open-label, multicentre, randomised, controlled, phase 3 trial.

Lancet (London, England)·2026

Children in all policies: lessons from a global collaboration to promote the health and wellbeing of children and future generations.

Lancet (London, England)·2026

A Rare Presentation of Acute Cholecystitis Mimicking Malignancy in a Young Male With Elevated IgG4.

Cureus·2026

Identification of <i>Leishmania major</i> and Other Causative Species in Syrian Patients Infected with Cutaneous Leishmaniasis.

Iranian journal of parasitology·2026

A map of intra- and intercellular immune responses across diverse in vitro stimuli and inflammatory disease.

Genome medicine·2026

Photonic waveguide chip-based nanoscopy visualizes rearrangements of the cortical actin cytoskeleton in activated Jurkat T cells.

Science advances·2026

Protocol for deep phenotyping of human antigen-specific T cells across conventional and unconventional subsets by 22-color spectral flow cytometry.

STAR protocols·2026

Rapid and accessible tumor necrosis factor alpha detection using digital nanoparticle sensors towards point-of-care cytokine monitoring.

Sensors and actuators. B, Chemical·2026

関連する実験動画

クローン病におけるレバミゾール

関連する概念動画

Downstaging of colorectal cancer by the National Bowel Cancer Screening programme in England: first round data from the first centre.

Earlier diagnosis and treatment of symptomatic bowel cancer: can it be achieved and how much will it improve survival?

Bradykinin regulates human colonic ion transport in vitro.

Infliximab therapy in Crohn's disease: a pragmatic approach?

Functional categories of TP53 mutation in colorectal cancer: results of an International Collaborative Study.

Pathological response following long-course neoadjuvant chemoradiotherapy for locally advanced rectal cancer.

1-month versus 12-month dual antithrombotic therapy after percutaneous coronary intervention in patients with atrial fibrillation (OPTIMA-AF): a multicentre, open-label, hybrid non-inferiority and superiority, randomised, controlled trial.

Multidomain lifestyle intervention for the prevention of cognitive decline in at-risk older adults in Latin America (LatAm-FINGERS): a single-blind, multicentre, randomised controlled trial.

Advancing the relevance of clinical trials for older patients.

Temocillin versus carbapenems for bacteraemia due to third-generation cephalosporin-resistant Enterobacterales in Spain (ASTARTÉ): a multicentre, phase 3, open-label, non-inferiority, randomised clinical trial.

Fixed-duration pirtobrutinib plus venetoclax-rituximab versus venetoclax-rituximab for patients with previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (BRUIN CLL-322): an open-label, multicentre, randomised, controlled, phase 3 trial.

Children in all policies: lessons from a global collaboration to promote the health and wellbeing of children and future generations.

A Rare Presentation of Acute Cholecystitis Mimicking Malignancy in a Young Male With Elevated IgG4.

Identification of <i>Leishmania major</i> and Other Causative Species in Syrian Patients Infected with Cutaneous Leishmaniasis.

A map of intra- and intercellular immune responses across diverse in vitro stimuli and inflammatory disease.

Photonic waveguide chip-based nanoscopy visualizes rearrangements of the cortical actin cytoskeleton in activated Jurkat T cells.

Protocol for deep phenotyping of human antigen-specific T cells across conventional and unconventional subsets by 22-color spectral flow cytometry.

Rapid and accessible tumor necrosis factor alpha detection using digital nanoparticle sensors towards point-of-care cytokine monitoring.

関連する実験動画

クローン病におけるレバミゾール

関連する概念動画

関連記事